Consideration of emerging pollutants in groundwater-based reuse concepts
Elimination of pathogens and emerging pollutants represents a key factor in integrated water resources management in arid regions. Within the SMART Jordan Valley project it is the objective of this study to assess the occurrence and examine the elimination of selected emerging pollutants and pathoge...
Veröffentlicht in: | Water science and technology : a journal of the International Association on Water Pollution Research. - 1986. - 66(2012), 6 vom: 24., Seite 1270-6 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2012
|
Zugriff auf das übergeordnete Werk: | Water science and technology : a journal of the International Association on Water Pollution Research |
Schlagworte: | Journal Article Research Support, Non-U.S. Gov't Pharmaceutical Preparations Soil Soil Pollutants Water Pollutants, Chemical |
Zusammenfassung: | Elimination of pathogens and emerging pollutants represents a key factor in integrated water resources management in arid regions. Within the SMART Jordan Valley project it is the objective of this study to assess the occurrence and examine the elimination of selected emerging pollutants and pathogens in waste water treatment and aquifer recharge. In batch and soil column studies non-chlorinated organophosphorous compounds (tri-n-butylphosphate, triphenylphosphate) and endocrine disruptors (e.g. 17-ß-estradiol, bisphenol A) proved to be biodegradable, while the X-ray contrast agents iomeprol and iopromide were eliminated in the soil columns only, and the chlorinated trialkylphosphates showed persistency. Treating waste water in a membrane bioreactor (MBR) in combination with powdered activated carbon (PAC) resulted in considerable removal rates also for the more persistent compounds such as the antiepileptic carbamazepine. Viruses were shown to be present in most of the Jordan Valley surface water samples. MBR treatment resulted in a decrease of MS2 bacteriophages used as model viruses |
---|---|
Beschreibung: | Date Completed 18.10.2012 Date Revised 16.11.2017 published: Print Citation Status MEDLINE |
ISSN: | 0273-1223 |
DOI: | 10.2166/wst.2012.290 |